Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Mar 21 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-21-2023-5

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated March 21, 2023, titled "Zydus receives final and tentative Approval from the USFDA for Tofacitinib Tablets, 5 mg and 10 mg, respectively".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases